NCT02210156

Brief Summary

The purpose of this study is to determine whether the consumption of a nutritional supplement with micronutrients and herbal extracts has an effect on the incidence of acute respiratory infections in susceptible adults. Our hypothesis is that subjects who consume the nutritional supplement will have a lower incidence and duration of acute respiratory infections in comparison with the placebo group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

August 4, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 6, 2014

Completed
Last Updated

August 7, 2014

Status Verified

August 1, 2014

Enrollment Period

3 months

First QC Date

August 4, 2014

Last Update Submit

August 5, 2014

Conditions

Keywords

Respiratory tract infectionIncidenceDietary supplementsMicronutrientsPlant extracts

Outcome Measures

Primary Outcomes (1)

  • Incidence of acute respiratory infections

    Number of subjects with at least one episode of acute respiratory infection according to supplementation group.

    90 days

Secondary Outcomes (12)

  • Mean episodes of acute respiratory infections

    90 days

  • Mean duration of acute respiratory infections

    90 days

  • Number of subjects with more than one acute respiratory infection episode

    90 days

  • Absenteeism

    90 days

  • Episode-related medication

    90 days

  • +7 more secondary outcomes

Study Arms (2)

Placebo

PLACEBO COMPARATOR

Two envelopes of the product in 240 ml of water in a disposable cup, 90 days of actual consumption.

Other: Placebo

Omniplus Supreme

EXPERIMENTAL

Two envelopes of the product in 240 ml of water in a disposable cup, 90 days of actual consumption.

Dietary Supplement: Omniplus Supreme

Interventions

Omniplus SupremeDIETARY_SUPPLEMENT

Two dietitians prepared the products (one preparer per product) by dissolving two envelopes of 20 ml of the product in 240 ml of water in a disposable cup, every day from Monday to Saturday during the intervention period (90 days of actual consumption). In order to maintain blinding, these dietitians then gave the prepared cups to two different supervisors who in turn gave the product to each participant for consumption (once-daily doses). The preparation and delivery of the product was carried out during two work shifts (morning and afternoon), depending on each participants work schedule. The supervisors recorded product administration and consumption for each participant on a control form.

Also known as: Food supplement with micronutrients and plant extracts
Omniplus Supreme
PlaceboOTHER

A product with maltodextrins, flavors and colorants without vitamins, minerals and plant extracts. Two dietitians prepared the products (one preparer per product) by dissolving two envelopes of 20 ml of the product in 240 ml of water in a disposable cup, every day from Monday to Saturday during the intervention period (90 days of actual consumption). In order to maintain blinding, these dietitians then gave the prepared cups to two different supervisors who in turn gave the product to each participant for consumption (once-daily doses). The preparation and delivery of the product was carried out during two work shifts (morning and afternoon), depending on each participants work schedule. The supervisors recorded product administration and consumption for each participant on a control form.

Placebo

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adult subjects (without active respiratory infections, or without diseases that compromise immune system)
  • Who presented no abnormalities in their laboratory tests (active infections, immunosuppression, renal or hepatic impairment)
  • Who did not take drugs that affect the immune system (anti-inflammatory drugs, antibiotics, steroids).

You may not qualify if:

  • Subjects with active acute respiratory infections.
  • Subjects with chronic respiratory disease requiring treatment other than bronchodilators at the time of assessment.
  • Subjects with diseases affecting the immune system (autoimmune illness, diabetes, etc.)
  • Pregnant women or currently nursing.
  • Subjects with cardiovascular disorders (uncontrolled hypertension) or neurological disorders (epilepsy).
  • Subjects with allergies to any components of the products.
  • Subjects with low treatment adherence (less than 80%).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Omnilife

Guadalajara, Jalisco, 44500, Mexico

Location

Related Publications (41)

  • Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005 Nov;5(11):718-25. doi: 10.1016/S1473-3099(05)70270-X.

    PMID: 16253889BACKGROUND
  • Calder PC, Kew S. The immune system: a target for functional foods? Br J Nutr. 2002 Nov;88 Suppl 2:S165-77. doi: 10.1079/BJN2002682.

    PMID: 12495459BACKGROUND
  • Manoharan A, Winter J. Tackling upper respiratory tract infections. Practitioner. 2010 Nov;254(1734):25-8, 2-3.

    PMID: 21166296BACKGROUND
  • Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab. 2007;51(4):301-23. doi: 10.1159/000107673. Epub 2007 Aug 28.

    PMID: 17726308BACKGROUND
  • Ramirez MT, Hernandez RL. Factor structure of the Perceived Stress Scale (PSS) in a sample from Mexico. Span J Psychol. 2007 May;10(1):199-206. doi: 10.1017/s1138741600006466.

    PMID: 17549893BACKGROUND
  • Stephen AI, Avenell A. A systematic review of multivitamin and multimineral supplementation for infection. J Hum Nutr Diet. 2006 Jun;19(3):179-90. doi: 10.1111/j.1365-277X.2006.00694.x.

    PMID: 16756533BACKGROUND
  • Goyal SK, Samsher, Goyal RK. Stevia (Stevia rebaudiana) a bio-sweetener: a review. Int J Food Sci Nutr. 2010 Feb;61(1):1-10. doi: 10.3109/09637480903193049.

    PMID: 19961353BACKGROUND
  • Gohil KJ, Patel JA, Gajjar AK. Pharmacological Review on Centella asiatica: A Potential Herbal Cure-all. Indian J Pharm Sci. 2010 Sep;72(5):546-56. doi: 10.4103/0250-474X.78519.

    PMID: 21694984BACKGROUND
  • Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE; Consorzio Interuniversitario Nazionale per la Bio-Oncologia, Italy. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology. 2007 May;17(5):541-52. doi: 10.1093/glycob/cwm014. Epub 2007 Feb 12.

    PMID: 17296677BACKGROUND
  • Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol. 2009 Sep;4(3):198-219. doi: 10.2174/157488409789375311. Epub 2009 Sep 1.

    PMID: 19500070BACKGROUND
  • Karkos PD, Leong SC, Arya AK, Papouliakos SM, Apostolidou MT, Issing WJ. 'Complementary ENT': a systematic review of commonly used supplements. J Laryngol Otol. 2007 Aug;121(8):779-82. doi: 10.1017/S002221510600449X. Epub 2006 Nov 24.

    PMID: 17125579BACKGROUND
  • Barrett B, Brown R, Rakel D, Mundt M, Bone K, Barlow S, Ewers T. Echinacea for treating the common cold: a randomized trial. Ann Intern Med. 2010 Dec 21;153(12):769-77. doi: 10.7326/0003-4819-153-12-201012210-00003.

    PMID: 21173411BACKGROUND
  • Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr. 1997 Aug;66(2):460S-463S. doi: 10.1093/ajcn/66.2.460S.

    PMID: 9250133BACKGROUND
  • Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. J Leukoc Biol. 2002 Jan;71(1):16-32.

    PMID: 11781377BACKGROUND
  • Rosler D, Fuchs N, Markolin G, Edler B, Kuklinski B, Kastenbauer T. [Reduction of influenza-like infections by a phytoextract-vitamin-combination: a randomized, double-blind, placebo-controlled study]. MMW Fortschr Med. 2012 Dec 17;154 Suppl 4:115-22. German.

    PMID: 23326930BACKGROUND
  • Liu Y, Jing H, Wang J, Zhang R, Zhang Y, Zhang Y, Xu Q, Yu X, Xue C. Micronutrients decrease incidence of common infections in type 2 diabetic outpatients. Asia Pac J Clin Nutr. 2011;20(3):375-82.

    PMID: 21859655BACKGROUND
  • Linday LA, Dolitsky JN, Shindledecker RD. Nutritional supplements as adjunctive therapy for children with chronic/recurrent sinusitis: pilot research. Int J Pediatr Otorhinolaryngol. 2004 Jun;68(6):785-93. doi: 10.1016/j.ijporl.2004.01.009.

    PMID: 15126020BACKGROUND
  • Linday LA, Shindledecker RD, Tapia-Mendoza J, Dolitsky JN. Effect of daily cod liver oil and a multivitamin-mineral supplement with selenium on upper respiratory tract pediatric visits by young, inner-city, Latino children: randomized pediatric sites. Ann Otol Rhinol Laryngol. 2004 Nov;113(11):891-901. doi: 10.1177/000348940411301108.

    PMID: 15562899BACKGROUND
  • Penny ME, Marin RM, Duran A, Peerson JM, Lanata CF, Lonnerdal B, Black RE, Brown KH. Randomized controlled trial of the effect of daily supplementation with zinc or multiple micronutrients on the morbidity, growth, and micronutrient status of young Peruvian children. Am J Clin Nutr. 2004 Mar;79(3):457-65. doi: 10.1093/ajcn/79.3.457.

    PMID: 14985222BACKGROUND
  • Begin F, Santizo MC, Peerson JM, Torun B, Brown KH. Effects of bovine serum concentrate, with or without supplemental micronutrients, on the growth, morbidity, and micronutrient status of young children in a low-income, peri-urban Guatemalan community. Eur J Clin Nutr. 2008 Jan;62(1):39-50. doi: 10.1038/sj.ejcn.1602682. Epub 2007 Feb 14.

    PMID: 17299460BACKGROUND
  • Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA. 2002 Aug 14;288(6):715-21. doi: 10.1001/jama.288.6.715.

    PMID: 12169075BACKGROUND
  • Avenell A, Campbell MK, Cook JA, Hannaford PC, Kilonzo MM, McNeill G, Milne AC, Ramsay CR, Seymour DG, Stephen AI, Vale LD. Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial. BMJ. 2005 Aug 6;331(7512):324-9. doi: 10.1136/bmj.331.7512.324.

    PMID: 16081445BACKGROUND
  • Croci DO, Cumashi A, Ushakova NA, Preobrazhenskaya ME, Piccoli A, Totani L, Ustyuzhanina NE, Bilan MI, Usov AI, Grachev AA, Morozevich GE, Berman AE, Sanderson CJ, Kelly M, Di Gregorio P, Rossi C, Tinari N, Iacobelli S, Rabinovich GA, Nifantiev NE; Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO), Italy. Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed. PLoS One. 2011 Feb 28;6(2):e17283. doi: 10.1371/journal.pone.0017283.

    PMID: 21387013BACKGROUND
  • Erickson KL, Medina EA, Hubbard NE. Micronutrients and innate immunity. J Infect Dis. 2000 Sep;182 Suppl 1:S5-10. doi: 10.1086/315922.

    PMID: 10944478BACKGROUND
  • Lofgren E, Fefferman NH, Naumov YN, Gorski J, Naumova EN. Influenza seasonality: underlying causes and modeling theories. J Virol. 2007 Jun;81(11):5429-36. doi: 10.1128/JVI.01680-06. Epub 2006 Dec 20. No abstract available.

    PMID: 17182688BACKGROUND
  • Nahas R, Balla A. Complementary and alternative medicine for prevention and treatment of the common cold. Can Fam Physician. 2011 Jan;57(1):31-6.

    PMID: 21322286BACKGROUND
  • Puertollano MA, Puertollano E, de Cienfuegos GA, de Pablo MA. Dietary antioxidants: immunity and host defense. Curr Top Med Chem. 2011;11(14):1752-66. doi: 10.2174/156802611796235107.

    PMID: 21506934BACKGROUND
  • Gestal-Otero JJ, Takkouche B, Blasco-Huelva P. Infecciones respiratorias agudas. Gripe. En: Piédrola-Gil G, editor. 1oa ed. Medicina preventiva y salud pública. Barcelona: Masson; 2001. p. 491-505

    BACKGROUND
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.

    PMID: 6668417BACKGROUND
  • International Physical Activity Questionnaire [Web site]; 2005 [access november 4th 2011]. IPAQ Research Committee. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ). Short and long forms. Available in: http://www.ipaq.ki.se/scoring.pdf.

    BACKGROUND
  • Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.

    PMID: 12900694BACKGROUND
  • Marfell-Jomes M, Olds T, Stewart A, Carter L. Estándares internacionales para la evaluación antropométrica. Revisión 2008. South Africa: Sociedad Internacional para el Avance de la Cineantropometría; 2008.

    BACKGROUND
  • World Health Organization [Web site]. Geneva: The Organization; 2006 [updated november 11th 2011; access november 11th 2011]. BMI classification. Available in: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.

    BACKGROUND
  • Vizmanos B, Bernal MF. Signos vitales. In: López-Uriarte P, Hunot C, Altamirano M, Macedo G, Vizmanos B, editors. Manual de prácticas de evaluación del estado nutricio. 1st ed. Guadalajara: La noche; 2007. p. 25-30.

    BACKGROUND
  • Gupta S, Rajauria G, Sbu-Ghannam N. Study of the microbial diversity and antimicrobial properties of Irish edible brown seaweeds. Int J Food Sci Technol. 2010;45:482-9.

    BACKGROUND
  • Jensen GS, Ginsberg DJ, Huerta P, Citton M, Drapeau C. Consumption of Aphanizomenon flos-aquae has rapid effects on the circulation and function of immune cells in humans. A novel approach to nutritional mobilization of the immune system. JANA 2000;2:50-8.

    BACKGROUND
  • Castelloti C. Algas. Su uso terapéutico y nutricional. 1st ed. Madrid: Editorial Dilema; 2008.

    BACKGROUND
  • Luabeya KK, Mpontshane N, Mackay M, Ward H, Elson I, Chhagan M, Tomkins A, Van den Broeck J, Bennish ML. Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South African children: a randomized controlled trial. PLoS One. 2007 Jun 27;2(6):e541. doi: 10.1371/journal.pone.0000541.

    PMID: 17593956BACKGROUND
  • McNair F, Heuchert JWP. Manual for the profile of mood states. San Diego (CA): Educational and Industrical Testing Service; 1971.

    BACKGROUND
  • Mills S, Bone K. The essential guide to herbal safety. 1st ed. Philadelphia: Elsevier; 2005.

    BACKGROUND
  • Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007 Oct;98 Suppl 1:S29-35. doi: 10.1017/S0007114507832971.

    PMID: 17922955BACKGROUND

MeSH Terms

Conditions

Respiratory Tract Infections

Interventions

Dietary SupplementsMicronutrientsPlant Extracts

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesNutrientsPlant PreparationsBiological ProductsComplex MixturesPharmaceutical Preparations

Study Officials

  • María F. Bernal-Orozco, Ph.D.

    Omnilife Manufactura, SA de CV

    STUDY DIRECTOR
  • Margarita Posada-Falomir, B.Sc.(Nutr.)

    Omnilife Manufactura, SA de CV

    PRINCIPAL INVESTIGATOR
  • Rafael Ortega-Orozco, M.D.

    Omnilife Manufactura, SA de CV

    PRINCIPAL INVESTIGATOR
  • Elvia Silva-Villanueva, M.Sc.(O.H).

    Omnilife Manufactura, SA de CV

    PRINCIPAL INVESTIGATOR
  • Gabriela Macedo-Ojeda, Ph.D.

    University of Guadalajara

    PRINCIPAL INVESTIGATOR
  • Yolanda F. Marquez-Sandoval, Ph.D.

    University of Guadalajara

    PRINCIPAL INVESTIGATOR
  • Barbara Vizmanos-Lamotte, M.D., Ph.D

    University of Guadalajara

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2014

First Posted

August 6, 2014

Study Start

January 1, 2012

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

August 7, 2014

Record last verified: 2014-08

Locations